Theriva biologics to participate in the b. riley securities annual oncology conference

Rockville, md., jan. 16, 2024 (globe newswire) -- theriva biologics, inc. (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will participate in a fireside chat at the b. riley securities oncology conference to be held virtually on thursday, january 18, 2024 at 9:30 a.m. et.
TOVX Ratings Summary
TOVX Quant Ranking